TCT-417 Treatment of coronary artery disease with a new-generation drug-coated balloon: preliminary results from the Italian Elutax SV Registry

drug-coated balloons (DCB) have shown to be a valuable alternative to stents for the treatment of in-stent restenosis, and there is some initial evidence of their efficacy for the treatment of small coronary vessels. Newer generation DCB were developed to overcome the reduced deliverability of the